<DOC>
	<DOCNO>NCT02358044</DOCNO>
	<brief_summary>This study compare grazoprevir ( MK-5172 ) plus elbasvir ( MK-8742 ) treatment sofosbuvir ( SOF ) plus Pegylated Interferon plus Ribavirin ( RBV ) [ PR ] treatment treatment-naïve prior PR treatment failure participant chronic Hepatitis C Virus ( HCV ) genotype ( GT ) 1 , GT4 , GT6 infection . The primary objective compare efficacy ( assess percentage participant achieve sustain virologic response 12 week end study treatment [ SVR12 ] ) safety grazoprevir plus elbasvir treatment arm SOF plus PR treatment arm . The primary hypothesis percentage participant achieve SVR12 grazoprevir plus elbasvir treatment arm non-inferior SOF plus PR treatment arm .</brief_summary>
	<brief_title>Efficacy Safety Combination Grazoprevir ( MK-5172 ) /Elbasvir ( MK-8742 ) Versus Sofosbuvir + Pegylated Interferon + Ribavirin Hepatitis C Virus Genotype 1 , 4 6 Infection ( MK-5172-077 )</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Peginterferon alfa-2b</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<criteria>Weigh ≥40 kg ≤125 kg document chronic HCV GT1 , GT4 , GT6 infection cirrhosis/absence cirrhosis define liver biopsy , Fibroscan , FibroSure® either treatment naïve PR Null Responder , PR Partial Responder , PR Prior Relapser participant partner agree use least use least 2 effective method contraception least 2 week prior Day 1 continue 6 month last dose study drug , longer dictate local regulation evidence decompensated liver disease coinfected hepatitis B virus ( e.g . hepatitis B surface antigen positive ) human immunodeficiency virus history malignancy ≤5 year prior sign inform consent , evaluation active suspected malignancy cirrhosis liver image within 6 month Day 1 show evidence hepatocellular carcinoma ( HCC ) evaluation HCC follow condition : immunologicallymediated disease , organ transplant cornea hair , poor venous access precludes routine peripheral blood sampling , history gastric surgery malabsorption disorder , medical condition requiring , likely require , chronic systemic administration corticosteroid course trial , history chronic hepatitis cause HCV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>